ANNEX 4 RECOMMENDATIONS ON COMPOUNDS ON THE AGENDA Acceptable Daily Recommended Intake (ADI) Maximum Residue Substance for human beings Level (MRL) Anthelmintic drug Albendazole 0.0.05 mg per kg Muscle, fat, and milk; of body weight 0.1 mg/kg Liver and kidney: 5 mg/kg Anti-protozoal agents (5-Nitroimidazoles) Dimetridazole Not allocated1 No MRLs allocated1 Ipronidazole Not allocated1 No MRLs allocated1 Metronidazole Not evaluated2 No MRLs allocated2 Ronidazole 0-0.025 mg per kg No MRLs allocated4 of body weight3 Antimicrobial sulfonamides Sulfadimidine5 0-0.004 mg per kg Meat, liver, kidney, of body weight3 and fat: 0.3 mg/kg as total residue; 0.1 mg/kg as sulfadimidine Milk: 0.05 mg/kg as total residue; 0.025 mg/kg as sulfadimidine Sulfathiazole Not allocated1 No MRLs allocated1 Growth promoter Trenbolone acetate 0-0.02 µg per kg Muscle: 2 µg per kg body weight as ß-trenbolone Liver: 10 µg per kg as alpha-trenbolone Trypanosides Diminazene Not allocated1 No MRLs allocated1 Isometadmidum Not allocated1 No MRLs allocated1 1. Insufficient toxicological information was available to establish either an ADI or MRL (see Annex 5). 2 This substance was not evaluated because toxicological data were not made available to the Committee. 3. Temporary acceptance (see Annex 5). 4. Insufficient information was available to establish MRLs (See Annex 5). 5. This substance was on the agenda under the name "sulfamethazine". It was evaluated under the name "sulfadimidine", which is the INN (International Non-proprietary Names) designation for this compound.
See Also: Toxicological Abbreviations